(Q41188337)

28 September 2017

title

Homocysteine modification of HLA antigens and its immunological consequences (English)

1 reference

28 September 2017

1 reference

2

Wordsworth P

1 reference

28 September 2017

Gao XM

1

1 reference

28 September 2017

McMichael AJ

3

1 reference

28 September 2017

Kyaw MM

4

1 reference

28 September 2017

Seifert M

5

1 reference

28 September 2017

Rees D

6

1 reference

28 September 2017

Dougan G

7

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

European Journal of Immunology

28 September 2017

published in

1 reference

28 September 2017

volume

26

1 reference

28 September 2017

issue

7

1 reference

28 September 2017

page(s)

1443-1450

1 reference

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

The use of cyst(e)ine in the removal of protein-bound homocysteine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Reiter's disease and HL-A 27.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

High Association of an HL-A Antigen, W27, with Ankylosing Spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Ankylosing spondylitis and HL-A 27.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Immunology of reactive arthritides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

The origins of HLA-A,B,C polymorphism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Identification of self peptides bound to purified HLA-B27

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Structure of peptides associated with class I and class II MHC molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Peptides naturally presented by MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Oligopeptide biases in protein sequences and their use in predicting protein coding regions in nucleotide sequences

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Guilt by association: HLA-B27 and ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Chemical reactivity of an HLA-B27 thiol group

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260707

7 January 2021

Identifiers

DOI

10.1002/EJI.1830260707

1 reference

28 September 2017

1 reference